Numbers
What the research says
- Tirzepatide: average losses of up to 22.5% of body weight (Drugs.com).
- Semaglutide: averages of up to 21% with certain formulations and doses (Drugs.com).
- A 2024 meta-analysis of 53 studies and 21,349 patients found tirzepatide worked best against placebo.
- Oral semaglutide: 16.6% average loss over 64 weeks when taken as directed, versus roughly 3% on placebo (OASIS 4).